Navigation Links
New ovarian stimulation technique offers more cancer patients the chance to preserve their fertility
Date:7/7/2008

Barcelona, Spain: Researchers have shown for the first time that it is possible to stimulate a woman's ovaries to produce eggs for collection during the final phase of the menstrual cycle. The finding offers the chance for more women who have been diagnosed with cancer to restore their fertility following chemotherapy or radiotherapy cancer treatments that can seriously damage the ovaries, often permanently. The findings were presented at the 24th annual meeting of the European Society of Human Reproduction and Embryology in Barcelona today (Monday).

At present, women who have been diagnosed with cancer may want to have some of their eggs collected and frozen in order to give them an opportunity of having children once their cancer treatment has finished. However, conventional protocols involve starting ovarian stimulation only at the beginning of a woman's menstrual cycle (the day that menstruation starts). Therefore, if the cancer diagnosis is made at any other time in the cycle, a woman could wait up to six weeks before it would be possible to collect eggs (or oocytes) after ovarian stimulation. For many women, six weeks is too long to wait before starting cancer treatment.

Dr Michael von Wolff, vice-director of the Department of Gynaecological Endocrinology and Reproduction Medicine at the University of Heidelberg, Germany, told a conference news briefing: "Depending on what phase of her menstrual cycle a woman is in when she receives a cancer diagnosis, it can take between two and six weeks to start ovarian stimulation and collect oocytes. Two weeks is an acceptable amount of time in many diseases to wait before starting a cancer treatment such as chemotherapy, but three to six weeks is far too long."

The researchers conducted a pilot study in 40 women in 2007 to see whether it would be possible to initiate ovarian stimulation during the luteal phase (the phase in the menstrual cycle from ovulation to the start of the next men
'/>"/>

Contact: Emma Mason
wordmason@mac.com
34-932-308-810
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Pelvic Exams Can Help Spot Ovarian Cancer
4. Study fuels debate over whether exercise and body size influence ovarian cancer risk
5. Experimental drug boosts survival in recurrent ovarian cancer
6. New Ovarian Cancer Biomarker Research Act Introduced
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. More Fiber, Less Fat Help Prevent Ovarian Cancer
9. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
10. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)
11. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... the 20th sweetFrog store operating in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, located at 2916 US-75, Sherman, TX 38652, will have ...
(Date:8/3/2015)... ... 03, 2015 , ... As reported in a July ... “Atlanta Plastic” is getting attention for moving outside traditional ethnic stereotypes when it ... cast of doctors and patients. Beverly Hills based plastic surgeon Payam Jarrah-Nejad, M.D., ...
(Date:8/3/2015)... NJ (PRWEB) , ... August 03, 2015 , ... ... a finalist in 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright ... and for B2B brands. BESLER Consulting's campaign for the launch of their Readmissions ...
(Date:8/3/2015)... Somerset, N.J. (PRWEB) , ... August 03, 2015 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... Administration has accepted for review OPKO’s New Drug Application for a new treatment ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... The art ... experience. Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely ... has decided to share her cookbook Recipes from My Persian Kitchen with the world. ...
Breaking Medicine News(10 mins):Health News:sweetFrog Reopens Texas Store Today 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2
... to extend their reach beyond the youth segments as far as ... For the aging population in Japan has taken to "Brain Train" ... Nintendo has sold 3.3 million of its "Brain Training for Adults" ... out to those who were not interested in video games ... ...
... People plan various phases of their life like education, marriage, ... do not plan for the most important thing - death. ... University of New Mexico's Health Sciences Center wants people to ... ,"We're all going to die. But we do not address ...
... (KSHV) and certain forms of lymphoma has been ... ,Researchers at the National Institute of Allergy ... human cell surface molecule involved in infection by ... Kaposi's sarcoma and certain forms of lymphoma. Kaposi's ...
... sporting sunglasses, don’t be surprised. They don't mean to be ... their looks! //Sunglasses have always afforded creative utility benefits and ... use. There is one more out of the hat use ... who have revealed that sunglasses can help reduce jet lag. ...
... culprit behind childhood obesity is that the amount of junk ... of hours they spend// watching television. Researchers analyzed the dietary ... countries. , It was found that consumption of ... in front of the idiot box. Researchers at the universities ...
... which is a male-dominated Muslim society, five women undergo sex ... are expected to fully cover themselves in public and ban ... relative. ,Hence five Saudi women took a sex ... developed a psychologic complex. ,Al Watan newspaper quoted ...
Cached Medicine News:Health News:Plan for Death, Health Center Advises People 2Health News:Virus Causing Kaposi's Sarcoma Discovered 2Health News:Virus Causing Kaposi's Sarcoma Discovered 3Health News:TV Viewing Increases Intake of Junk Food 2
(Date:8/3/2015)... -- Landauer, Inc. (NYSE: LDR ), a recognized leader ... medical physics services and high quality medical consumable accessories, ... fiscal third quarter 2015 after the market close on ... will also host a conference call for investors on ... (10:00 a.m. Eastern Time). Investors may access the live ...
(Date:8/3/2015)... 3, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... reported financial results for the three and six months ... , On July 23, 2015, the Committee for ... opinion for Zalviso™ for the management of acute moderate-to-severe ...
(Date:8/3/2015)... , Aug. 3, 2015  LEO Pharma supports ... Administration (FDA) to include psoriasis as one of eight ... Development Initiative i .  Psoriasis is an autoimmune disease ... subsequent comorbidities, affecting 7.5 million people in the US ... Pharma,s ongoing commitment to supporting patients living with psoriasis, ...
Breaking Medicine Technology:Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 2LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 3
... Inc.,(Nasdaq: ITMN ) today announced that it ... pirfenidone in idiopathic pulmonary fibrosis (IPF) prior,to market open ... conference,call and webcast, with accompanying slide presentation, to discuss ... a.m. PST) on Tuesday,February 3. , ...
... led by Laurie Ozelius, Ph.D. at Mount Sinai School ... development of primary torsion dystonia, also known as DYT6 ... Research Foundation (DMRF), Dr. Ozelius and her colleagues have ... dystonia in Amish-Mennonite families, as well as in other ...
Cached Medicine Technology:InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3 2Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder 2
... low osmolar, nonionic, contrast media agent ... inert when injected intra-arterially. Each milliliter ... ioversol, 3.6 mg of tromethamine as ... edetate calcium disodium as a stabilizer. ...
... OMNIPAQUE is an X-ray ... adults and children for: angiography, ... and computed tomography of the ... Arthrography, endoscopic retrograde cholangio (pancreato) ...
... IMAGOPAQUE is a non-ionic monomeric contrast medium ... adults and children. After a decade of ... million examinations, IMAGOPAQUE has proven to be ... in hundreds of radiology departments.Results from large ...
... The only MR contrast agent FDA-approved for ... a gadolinium based, IV contrast media for ... liver. OptiMARK has convenient packaging options ... packaged for efficient, problem-free delivery. You can ...
Medicine Products: